Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Prepaid Assets (2022 - 2025)

Historic Prepaid Assets for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $12.3 million.

  • Centessa Pharmaceuticals' Prepaid Assets fell 2232.15% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year decrease of 2232.15%. This contributed to the annual value of $10.5 million for FY2024, which is 4951.03% down from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Prepaid Assets of $12.3 million as of Q3 2025, which was down 2232.15% from $8.9 million recorded in Q2 2025.
  • Centessa Pharmaceuticals' Prepaid Assets' 5-year high stood at $22.7 million during Q3 2023, with a 5-year trough of $8.9 million in Q2 2025.
  • Its 4-year average for Prepaid Assets is $16.2 million, with a median of $16.4 million in 2022.
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 8589.36% in 2023, then tumbled by 5237.71% in 2025.
  • Centessa Pharmaceuticals' Prepaid Assets (Quarter) stood at $19.9 million in 2022, then rose by 3.95% to $20.7 million in 2023, then plummeted by 49.51% to $10.5 million in 2024, then grew by 17.93% to $12.3 million in 2025.
  • Its last three reported values are $12.3 million in Q3 2025, $8.9 million for Q2 2025, and $13.6 million during Q1 2025.